A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2011
11/17/2011	CA2799177A1 Enhanced death receptor agonists
11/16/2011	EP2386859A2 Diagnostic tumor markers
11/16/2011	EP2386319A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/16/2011	EP2386307A1 Compositions for preventing and treating cancer containing egg whites combined with blue vitriol
11/16/2011	EP2386305A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
11/16/2011	EP2386304A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
11/16/2011	EP2386291A1 Vaginally administrable progesterone-containing tablets and method for preparing same
11/16/2011	EP2385830A1 Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor
11/16/2011	EP2385763A1 Methods for treating vascular leak syndrome
11/16/2011	EP2003130B1 Novel pyridine derivative having anti-helicobacter pylori activity
11/16/2011	EP1654285B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/16/2011	EP1652533B1 Heart-slowing drug containing short-acting beta-blocker as the active ingredient
11/16/2011	CN1874790B Therapeutic agent for mesothelioma
11/16/2011	CN1777415B Medicinal composition containing edible acid or its acid salt and its use
11/16/2011	CN102245211A Combined drug administration
11/16/2011	CN102245177A Oral composition
11/16/2011	CN102245174A Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents
11/16/2011	CN102242080A Method for treating or diagnosing heart failure or tendency of heart failure or improving functions of myocardial cells by miR-24 (MicroRNA-24)
11/16/2011	CN102240394A Use of interleukin-1receptor antagonist (IL-1Ra), and pharmaceutical compositions of IL-1Ra
11/16/2011	CN102240040A Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
11/16/2011	CN101511372B Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent
11/16/2011	CN101102758B Thyroid hormone analogs for promoting angiogenesis
11/15/2011	US8058442 Neuroprotective iron chelators and pharmaceutical compositions comprising them
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL
11/15/2011	US8058400 Composition and method for modulating dendritic cell-t cell interaction
11/15/2011	US8058399 Multispecific reagent for selectively stimulating cell surface receptors
11/15/2011	US8058398 Modified G-CSF polypeptide
11/15/2011	US8058305 Pyrrolidine derivatives as prostaglandin modulators
11/15/2011	US8058304 Merged ion channel modulating compounds and uses thereof
11/15/2011	US8058301 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058245 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2011	US8058239 HMGB1 protein inhibitorsand/or antagonists for the treatment of vascular diseases
11/15/2011	US8058238 High purity lipopeptides
11/15/2011	US8058233 Modification of feeding behavior using PYY and GLP-1
11/15/2011	US8058025 Methods for determining efficacy of chemotherapeutic agents
11/15/2011	US8057997 Nucleic acid binding compounds containing pyrazolo[3,4-D]pyrimidine analogues of purin-2,6-diamine and their uses
11/15/2011	US8057812 Medium chain peroxycarboxylic acid compositions
11/15/2011	US8057803 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/15/2011	US8057799 ErbB interface peptidomimetics and methods of use thereof
11/15/2011	US8057791 Human antibodies specific to KDR and uses thereof
11/15/2011	CA2534910C Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2444282C Preparation for hair and/or scalp
11/15/2011	CA2429979C Treatment of statin side effects
11/15/2011	CA2410387C Polymerizable compositions and methods of use
11/15/2011	CA2372929C Medicament for topical application
11/15/2011	CA2368772C Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
11/15/2011	CA2352537C Tgf.beta.1-inhibitor peptides
11/15/2011	CA2343979C Human interleukin-b50, therapeutic uses
11/15/2011	CA2339879C Carbonyl-stress improving agent and peritoneal dialysate
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/10/2011	WO2011139811A1 Nicotine-containing pharmaceutical compositions
11/10/2011	WO2011138956A1 Novel prenylarene compound and use thereof
11/10/2011	WO2011080502A3 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/10/2011	WO2011080501A3 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/10/2011	US20110275706 Pharmaceutical Compositions Containing Lipase Inhibitors
11/10/2011	US20110275691 Methods of treating headaches using 5-ht agonists in combination with long-acting nsaids
11/10/2011	US20110275672 Methods for treating cancers using polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275584 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss
11/10/2011	US20110274649 T-cell vaccination with viral vectors via mechanical epidermal disruption
11/10/2011	US20110274645 Methods of performing medical procedures that promote bone growth, methods of making compositions that promote bone growth, and apparatus for use in such methods
11/09/2011	EP2385124A2 Peptides or peptide analogues for modulating the binding of a PDZ protein and a PL protein
11/09/2011	EP2385058A1 Method for detecting the expression of a human endogenous retrovirus envelope protein and uses of a coding gene for said protein
11/09/2011	EP2384768A1 Phenylpropionamide compounds and the use thereof
11/09/2011	EP2384752A1 Combination preparation comprising a phosphodiesterase inhibitor and a COX inhibitor for treating cancer
11/09/2011	EP2384318A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
11/09/2011	EP2384198A2 Pharmaceutical compositions and methods of treating neurological insults
11/09/2011	EP2384193A2 Vitamin d promoting sunscreen
11/09/2011	EP1845964B1 Antimicrobial compositions comprising a jasmonic acid compound as active agent
11/09/2011	EP1813623B1 Purinenucleoside derivative modified in 8-position and medicinal use thereof
11/09/2011	EP1689405B1 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance
11/09/2011	EP1663103B1 Compositions of botanical extracts for cancer therapy
11/09/2011	EP1661583B1 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic
11/09/2011	EP1383516B1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
11/09/2011	EP1370539B1 Hiv inhibiting n-aminoimidazole derivatives
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	EP1001815B1 Vectors derived from antibodies for transferring substances into cells
11/09/2011	CN1946456B Alcohol metabolism moderating composition
11/09/2011	CN1845920B 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
11/09/2011	CN1681512B Use of 2,3-benzodiazepines in preparing medicine for treatment of basal ganglia-related movement disorders
11/09/2011	CN102238964A Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
11/09/2011	CN102233132A Application of VEGF acceptor fusion proteins in preparation of drugs for inhibiting growth of ocular surface neovascularization
11/09/2011	CN102232934A Pulsatile pellet, pulsatile orally disintegrating tablet containing same, and preparation methods and applications thereof
11/09/2011	CN101961306B Preparation method of low melting point drug solid dispersion
11/09/2011	CN101890135B Antidepressant traditional Chinese medicine composition and application thereof
11/09/2011	CN101785858B Medicine combination containing isosorbide mononitrate for treating high blood pressure
11/09/2011	CN101716230B Complex preparation of stephanotis and antibiotic for treating infectious disease
11/09/2011	CN101396560B Medicine composition for treating polycystic kidney disease and use thereof
11/09/2011	CN101343251B Thrombopoietin mimetics
11/09/2011	CN101269111B Method for extracting alpha-diastase restrainer from phaseolus limensis
11/08/2011	US8055491 System and methods for optimized drug delivery and progression of diseased and normal cells
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8053206 Antagonists of HMG1 for treating inflammatory conditions
11/08/2011	US8052981 Mono- and disaccharide derivatives
11/08/2011	US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/08/2011	US8052972 Remedies for inflammatory bowel diseases
11/08/2011	CA2569674C Sublingual buccal effervescent

1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 1151